Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 5/20 | 0.64 |
| ▸ | IL1RN | P18510 | 2/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.46 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8191935 | 0.88 | ANPEP (0.73) | ANPEPIL1RNERAP2ERAP1 | |
| SCHEMBL9513734 | 0.84 | ANPEP (0.77) | ANPEP | |
| SCHEMBL9513876 | 0.78 | ANPEP (1.00) | ANPEPIL1RNERAP2ERAP1 | |
| SCHEMBL3478078 | 0.74 | ANPEP (0.49) | ANPEP | |
| SCHEMBL1718547 | 0.73 | ANPEP (1.00) | ANPEPIL1RNERAP2ERAP1 | |
| SCHEMBL1718097 | 0.72 | IL1RN (0.66) | ANPEPIL1RNERAP2ERAP1 | |
| Hydrochloric Acid SCHEMBL3230097 | 0.72 | ANPEP (1.00) | ANPEPIL1RNERAP2ERAP1 | |
| SCHEMBL8713911 | 0.72 | ANPEP (0.44) | ANPEP | |
| Hydrochloric Acid SCHEMBL3226375 | 0.71 | IL1RN (0.64) | ANPEPIL1RNERAP2ERAP1 | |
| Hydrochloric Acid SCHEMBL8717493 | 0.71 | ANPEP (0.43) | ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2084125-B1 | AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY | UNIV HAUTE ALSACE (FR) | 2012-01-11 | — | — | EP | disclosed |
| US-20100069504-A1 | AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY | UNIVERSITE DE HAUTE ALSACE (FR) | 2010-03-18 | — | — | US | disclosed |
| US-20100069504-A1 | AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY | UNIVERSITE DE HAUTE ALSACE (FR) | 2010-03-18 | — | — | US | disclosed |
| WO-2008059141-A1 | AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY | UNIVERSITE DE HAUTE ALSACE (FR) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069504-A1 | AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY | ANPEP, ENPEP, DNPEP | ANPEP 1/4885IL1RN 985/4885ERAP2 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.